In addition, inhibition of histone deacetylase (HDAC) signaling sensitized cancer cells to melatonin treatment 19, indicating that melatonin in combination with HDAC inhibitors may be a potential therapeutic intervention for human cancer. This evidence concerns the gene HDAC9 and cancer.